We use essential cookies to make our site work. With your consent, we may also use non-essential cookies to improve user experience and analyze website traffic. By clicking "Accept," you agree to our website's cookie use as described in our Privacy Policy.
ACCEPTDenyPREFERENCES
+

Link to Healthcare Professionals Site

The information contained in this section is intended for U.S. healthcare professionals only.

Enter the SiteCancel
+

Link to Healthcare Professionals Site

The information contained in this section is intended for U.S. healthcare professionals only.

Enter the SiteCancel

No more fighting over treatment

Your kid is different, treat them different. Instead of your child wearing an eyepatch to school they can watch TV at home

Find a prescriber

Innovative binocular dual-acting mechanism: Contrast reduction and dichoptic masking. Convey importance of dichoptic masking in MOA–connect to efficacy results

Luminopia is the first FDA-cleared, dual-acting binocular treatment for lazy eye.

Visuals are dulled in the strong eye to help strengthen the weaker eye4

Opposite parts of the image in both eyes are blocked which teaches the brain to use both eyes together to see the full image5

HAVE QUESTIONS? Check out our FAQs

Our proprietary software includes 75 shows—that’s 3,100+ episodes of carefully curated content. No extra subscriptions required.

Kid-friendly shows include favorites such as Sesame Street®, SpongeBob SquarePants™, Wild Kratts®—all without the need for a separate subscription.
The Loud House™
Wild Kratts®
Sponge Bob SquarePants™
Puss in Boots™
Project Mc2™
How To Train Your Dragon™
Arthur®
Dora the Explorer™

Not only is Luminopia clinically proven, but it’s also parent and child approved1-3

  • 86% of children saw vision improvement with Luminopia

  • Luminopia even works in patients who have been treated with other therapies like patching or drops

  • Treatment is only 1 hour per day, 6 days a week

FIND A PRESCRIBER NEAR YOU

86%

of children saw vision improvement with Luminopia

94%

of parents prefer Luminopia over patching3
  • Most common side effect reported were headaches (14.3% Luminopia vs. 1.7% control), all graded as mild and not lasting
  • No cases of nausea, myopia, or reverse lazy eye (amblyopia) reported
Indication
Luminopia has been shown to improve visual clarity in amblyopia (lazy eye) patients, aged 4-7, associated with vision imbalance and/or with mild crossed eye. Luminopia is intended to be used as an addition to full-time glasses, which should also be worn under the headset during Luminopia treatment. A prescription for Luminopia is required. It should be used at home.
Safety
  • No serious side effects reported with Luminopia
  • Most common side effect reported were headaches (14.3% Luminopia vs. 1.7% control), all graded as mild and not lasting
  • Cases of new or worsening eye-turn were balanced between groups (7.1% Luminopia vs. 8.5% control)
  • Rate of all ocular adverse events similar between groups
Important Information About Luminopia
  • Patients should only use Luminopia while wearing their prescribed glasses under the headset
  • Patients should wear Luminopia while seated or lying down
  • Patients with a history of light-induced seizures, serious medical conditions, new or worsening eye-turn, or double vision should contact their doctor for additional evaluation and permission
  • Patients should stop using Luminopia and contact their doctor for additional evaluation if they experience worsening vision in either eye, headache, nausea, eye strain that doesn't go away after usage, dizziness, or increased night terrors
Sources
  1. Luminopia. Directions for use, LBL-0001 Rev B. Luminopia, Inc.; 2024.
  2. Xiao, S., Angjeli, E., Wu, H. C., Gaier, E. D., Gomez, S., Travers, D. A., Binenbaum, G., Langer, R., Hunter, D. G., Repka, M. X., & Luminopia Pivotal Trial Group (2022). Randomized Controlled Trial of a Dichoptic Digital Therapeutic for Amblyopia. Ophthalmology, 129(1), 77–85. https://doi.org/10.1016/j.ophtha.2021.09.001.
  3. Data on file, 2023. Luminopia, Inc.
  4. Li, J., Thompson, B., Lam, C. S., Deng, D., Chan, L. Y., Maehara, G., Woo, G. C., Yu, M., & Hess, R. F. (2011). The role of suppression in amblyopia. Investigative ophthalmology & visual science, 52(7), 4169–4176. https://doi.org/10.1167/iovs.11-7233
  5. Birch, E. E., Jost, R. M., Wang, Y. Z., Kelly, K. R., & Giaschi, D. E. (2019). Impaired Fellow Eye Motion Perception and Abnormal Binocular Function. Investigative ophthalmology & visual science, 60(10), 3374–3380. https://doi.org/10.1167/iovs.19-26885
Study Design
Luminopia was evaluated in a clinical study of 117 patients, ages 4-7 with unilateral amblyopia (lazy eye) associated with anisometropia (vision imbalance) and/or strabismus (crossed eye). The clinical trial compared Luminopia 1 hour/day, 6 days/week with full-time glasses vs full-time glasses alone and measured the change in vision at 12 weeks.